AMASS Brands Group is making a bigger bet on the wellness beverage boom. The company, which just hit the public markets, on Thursday introduced a new line of electrolyte-focused mixers aimed at consumers who want to stay hydrated without the sugar crash.

The new AMASS Electrolyte Mixers are ready-to-drink beverages that can be enjoyed on their own or mixed with alcoholic and non-alcoholic spirits. The company says they contain zero added sugar, no artificial sweeteners, and 20 calories or fewer per serving. The blends use clean-label ingredients like Pacific sea salt and essential electrolytes to support hydration while keeping things premium.

AMASS only completed its direct listing on the Nasdaq Capital Market on May 20, so this is one of its first big product moves as a public company. It operates as a multi-category beverage platform focused on non-alcoholic, functional, and what it calls "alcohol 2.0" products. Its portfolio includes nine core brands, including Good Twin Non-Alcoholic Wine and Summer Water Rosé.

Since its launch, AMASS says it has generated more than $80 million in cumulative revenue, sold over 5.7 million bottles, and expanded distribution to more than 40,000 points of sale. That's a lot of bottles, and the company is clearly betting that the wellness trend has legs.

The timing makes sense. The electrolyte drinks market is projected to grow from roughly $40 billion in 2025 to more than $80 billion by 2034, according to estimates cited by AMASS. That growth is being driven by rising consumer interest in low-sugar, hydration-focused, and functional drink options. Basically, people want to drink something that tastes good and doesn't make them feel terrible.

Initial production of the Electrolyte Mixers is already done, and the products are available through AMASS's direct-to-consumer platform and select retail partners. The company plans to expand distribution further throughout 2026 as it scales the new line.

As for the stock: AMASS Brands (AMSS) shares were down 16.49% at $4.76 during premarket trading on Thursday, according to market data. That's a rough start, but the company is still in its early days as a public entity. The real test will be whether it can capture a meaningful slice of that $80 billion hydration market.